Equities are in rough and unpredictable seas

Equities 6 minutes to read

Peter Garnry

Head of Equity Strategy

Summary:  Equities are tilted towards a negative outlook short-term as volatility remains very high and equity valuations leave more accuses for investors to sell their equities as the short-term growth outlook is deteriorating from the spreading COVID-19. Obviously government and central bank intervention is coming creating a short-lived risk-on bounce but it will not alleviate the pain for the corporate sector. We also take a look at which industry groups and stocks that have done the best and worst during the period when COVID-19 hit the news in January.


Equities are caught in the middle of what may become the first global flu pandemic since the Hong Kong flu in 1968. S&P 500 was down 11.5% last week but was down a whopping 14.2% at the low. In today’s session the S&P 500 futures have fluctuated wildly currently down 0.8% from Friday’s close. While initial green shoots earlier today was off a good Chinese session and anticipation of a coordinated central bank action. Our view is that the Fed could cut by 50 bps. this week to try to infuse some stability and confidence into the system as markets the week of policy panic. But the impact will be short lived as a pandemic drives actual consumer behaviour that can cause an entire society to a halt as we have observed in China. That has real impact on earnings and growth.

Source: Saxo Group

The key factors influencing equities are inflation, growth, valuation, recession and volatility. Inflationary forces are likely in check for now and COVID-19 is currently a mixture of demand and supply shock should we anticipate little impact on inflation for now. Long-term growth is obviously not impacted unless COVID-19 turns into a nasty global recession with dramatic default in credit markets which could happen but we still put the probability in the low end. Short-term growth will obviously be impacted and that’s the real transmission into falling equities.

Equity valuations have come down quite a bit from high levels but are still hovering above the long-term average in the MSCI World Index. This in combination with downward pressure on earnings and revenue leaves more room for declines in equities over the coming six months as the COVID-19 spreads further.

The virus has obviously increased the recession risk for the US economy which already stood at 31% on a 12-month horizon based on numbers from January. This again is obviously negative in the short term. The final factor, and an important one, for short-term predictions is volatility. The VIX Index is currently at 41 which is significantly above the long-term equilibrium in the VIX term structure at the 22 level (see Lihn 2017). The current market state is characterized by negative return expectations, significant volatility and high kurtosis (fat tails). The 5-day average in VIX is currently 35 which is more than during the February 2018 volatility crash and Q4 2018 meltdown in equities.

Source: Saxo Group

There is also a major point to learn here. All the most critical information in financial markets happen in the tails. Last week’s significant decline in equities could likely mark a prolonged painful period for equities as the ‘perfection or TINA’ premium is removed from equities.

High sensitivity stocks to COVID-19

Not surprisingly the most sensitive industry groups to COVID-19 are passenger transportation which is dominated by airliners, but also industry groups such as Iron & Steel, Apparel, Oil & Gas, Restaurants & Gaming.

Some of the well-known names in those industries are: Ryanair, Southwest Airlines, Delta Air Lines, American Airlines, Air Canada, East Japan Railway, BHP Group, Fortescue Metals, Rio Tinto, Tata Steel, Nippon Steel, Burberry, LVMH, Under Armour, Christian Dior, Royal Dutch Shell, PetroChina, ConocoPhillips, Exxon Mobil, Baker Hughes, Carnival, Las Vegas Sands, Wynn Macau, MGM China and Intercontinental Hotels.

As we have been arguing many times in the past the technology sector has become a defensive sector. As the table shows software, hardware and technology services have all done well and then renewable energy is living its own life due to the focus on climate change.

Impact on earnings?

Equities are a long duration asset class pricing future growth and as such a one year shock to the economy, and in this case a virus, should not materially impact long-term growth which is a function of productivity growth (technological development) and human capital. Thus one year with declines in earnings per share should of course impact equity prices and valuations, but to what degree? In our next equities update we will provide a model for different paths in earnings and S&P 500 price levels.

Disclaimer

The Saxo Group entities each provide execution-only service and access to Analysis permitting a person to view and/or use content available on or via the website is not intended to and does not change or expand on this. Such access and use are at all times subject to (i) The Terms of Use; (ii) Full Disclaimer; (iii) The Risk Warning; (iv) the Rules of Engagement and (v) Notices applying to Saxo News & Research and/or its content in addition (where relevant) to the terms governing the use of hyperlinks on the website of a member of the Saxo Group by which access to Saxo News & Research is gained. Such content is therefore provided as no more than information. In particular no advice is intended to be provided or to be relied on as provided nor endorsed by any Saxo Group entity; nor is it to be construed as solicitation or an incentive provided to subscribe for or sell or purchase any financial instrument. All trading or investments you make must be pursuant to your own unprompted and informed self-directed decision. As such no Saxo Group entity will have or be liable for any losses that you may sustain as a result of any investment decision made in reliance on information which is available on Saxo News & Research or as a result of the use of the Saxo News & Research. Orders given and trades effected are deemed intended to be given or effected for the account of the customer with the Saxo Group entity operating in the jurisdiction in which the customer resides and/or with whom the customer opened and maintains his/her trading account. Saxo News & Research does not contain (and should not be construed as containing) financial, investment, tax or trading advice or advice of any sort offered, recommended or endorsed by Saxo Group and should not be construed as a record of our trading prices, or as an offer, incentive or solicitation for the subscription, sale or purchase in any financial instrument. To the extent that any content is construed as investment research, you must note and accept that the content was not intended to and has not been prepared in accordance with legal requirements designed to promote the independence of investment research and as such, would be considered as a marketing communication under relevant laws.

Please read our disclaimers:
- Notification on Non-Independent Investment Research (https://www.home.saxo/legal/niird/notification)
- Full disclaimer (https://www.home.saxo/en-sg/legal/disclaimer/saxo-disclaimer)

None of the information contained here constitutes an offer to purchase or sell a financial instrument, or to make any investments. Saxo Markets does not take into account your personal investment objectives or financial situation and makes no representation and assumes no liability as to the accuracy or completeness of the information nor for any loss arising from any investment made in reliance of this presentation. Any opinions made are subject to change and may be personal to the author. These may not necessarily reflect the opinion of Saxo Markets or its affiliates.

Saxo Capital Markets Pte Ltd ('Saxo Markets') is a company authorised and regulated by the Monetary Authority of Singapore (MAS) [Co. Reg. No.: 200601141M ] and is a wholly owned subsidiary of Saxo Bank A/S, headquartered in Denmark. Please refer to our General Business Terms & Risk Warning to consider whether acquiring or continuing to hold financial products is suitable for you, prior to opening an account and investing in a financial product.

Trading in financial instruments carries various risks, and is not suitable for all investors. Please seek expert advice, and always ensure that you fully understand these risks before trading. Trading in leveraged products such as Margin FX products may result in your losses exceeding your initial deposits. Saxo Markets does not provide financial advice, any information available on this website is ‘general’ in nature and for informational purposes only. Saxo Markets does not take into account an individual’s needs, objectives or financial situation.

The Saxo trading platform has received numerous awards and recognition. For details of these awards and information on awards visit www.home.saxo/en-sg/about-us/awards.

The information or the products and services referred to on this website may be accessed worldwide, however is only intended for distribution to and use by recipients located in countries where such use does not constitute a violation of applicable legislation or regulations. Products and Services offered on this website is not intended for residents of the United States and Japan. Please click here to view our full disclaimer.

This advertisement has not been reviewed by the Monetary Authority of Singapore.